Tandem Diabetes Care, Inc. (TNDM) FY2026 YTD Q2 P&L / Income Statement

Tandem Diabetes Care, Inc. (TNDM) FY2026 YTD Q2 P&L / Income Statement

Income statement for 2026-01-01 through 2026-06-30. View: Product and service. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Sales

501,781,000 US dollars

Cost of sales

220,213,000 US dollars

Gross profit

281,568,000 US dollars

Total operating expenses

312,794,000 US dollars

Operating loss

negative 31,226,000 US dollars

Other income (expense), net (calculated)

negative 9,309,000 US dollars

Loss before income taxes

negative 40,535,000 US dollars

Income tax expense (benefit)

1,026,000 US dollars

Net loss

negative 41,561,000 US dollars

Pump

225,078,000 US dollars

Supplies and other

276,703,000 US dollars

Selling, general and administrative

219,829,000 US dollars

Research and development

92,965,000 US dollars

Acquired in-process research and development expenses

0 US dollars

Litigation and settlement expense

0 US dollars

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.